SEI Investments’s Cidara Therapeutics CDTX Stock Holding History

SEI Investments’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,335	Closed	-$2.5M	–	3252
2025 Q4	$2.5M	Sell	11,335 -39,190	-78%	-$6.33M	﹤0.01%	1733
2025 Q3	$4.84M	Buy	50,525 +44,272	+708%	+$2.83M	0.01%	1310
2025 Q2	$305K	Buy	+6,253	New	+$150K	﹤0.01%	2402
2015 Q4	–	Sell	-411	Closed	-$104K	–	2535
2015 Q3	$104K	Buy	+411	New	+$117K	﹤0.01%	1776

SEI Investments's CDTX Position: Q1 2026 in Review

SEI Investments sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 11,335 shares — an estimated $2.5M sold.

SEI Investments first reported a position in CDTX in Q3 2015 and held it in 4 quarters. The position peaked at $4.84M in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

SEI Investments reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
SEI Investments sold 11,335 Cidara Therapeutics shares in Q1 2026, an estimated $2.5M.
SEI Investments first reported a position in Cidara Therapeutics in Q3 2015 and held it in 4 quarters.
SEI Investments's Cidara Therapeutics position peaked at $4.84M in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.